TherapeuticsMD Inc - TXMD Enterprise Value-to-Revenue Multiple

TherapeuticsMD Inc (TXMD) - corporate logo

TherapeuticsMD, Inc. (TXMD) transitioning to asset licensing activates operational leverage, as clearly demonstrated by the business value-to-revenue dynamics on this GURU.Markets chart, where 4208.00 defines the current value of the metric. Low demand elasticity for unique bioidentical drugs ensures stability, while revenue scalability is supported by the integration of new products into existing pharmacy networks.

TherapeuticsMD, Inc. - TXMD EV/Sales Multiple (period 11/23/2025 - 11/20/2026)

TherapeuticsMD Corp - analytical breakdowns and key metrics (TXMD)

- issuer market value details:
- cash and cash flow indicators:
Fundamental valuation:TXMD - TherapeuticsMD, Inc.
Brand item of TherapeuticsMD Inc

TherapeuticsMD, Inc. (TXMD) generates revenue from royalties on licensed women's health drugs, while a complete absence of debt makes its capital structure highly transparent. An EV/Sales valuation analysis allows for a comparison of the total business value against sales volume, where the narrowing range on the chart signals price consolidation and a latent risk of a sharp impulse should the patent status change.